CN110487941A - The method for building up and its finger-print of Taohong Siwu Tang preparation finger - Google Patents

The method for building up and its finger-print of Taohong Siwu Tang preparation finger Download PDF

Info

Publication number
CN110487941A
CN110487941A CN201910931400.7A CN201910931400A CN110487941A CN 110487941 A CN110487941 A CN 110487941A CN 201910931400 A CN201910931400 A CN 201910931400A CN 110487941 A CN110487941 A CN 110487941A
Authority
CN
China
Prior art keywords
retention time
mobile phase
peak
volume
percentage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201910931400.7A
Other languages
Chinese (zh)
Inventor
苗得足
胡清文
艾玉
焦启扬
颜世利
韩德凤
曾丽丽
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Reyoung Pharmaceutical Co Ltd
Original Assignee
Reyoung Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reyoung Pharmaceutical Co Ltd filed Critical Reyoung Pharmaceutical Co Ltd
Priority to CN201910931400.7A priority Critical patent/CN110487941A/en
Publication of CN110487941A publication Critical patent/CN110487941A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/04Preparation or injection of sample to be analysed
    • G01N30/06Preparation
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/62Detectors specially adapted therefor
    • G01N30/74Optical detectors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/86Signal analysis
    • G01N30/8675Evaluation, i.e. decoding of the signal into analytical information
    • G01N30/8686Fingerprinting, e.g. without prior knowledge of the sample components

Landscapes

  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Engineering & Computer Science (AREA)
  • Library & Information Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention belongs to drug detection technique fields, are specifically related to the method for building up and its finger-print of a kind of Taohong Siwu Tang preparation finger.Prepare Taohong Siwu Tang preparation testing sample solution, accurate testing sample solution of drawing injects high performance liquid chromatograph respectively, record finger-print, and the finger-print integrated signal of acquisition is imported into similarity evaluation, select in the chromatogram of different batches Taohong Siwu Tang preparation existing for chromatographic peak as shared peak;The standard control finger-print of Taohong Siwu Tang preparation is generated with mean value calculation method;Calculate the relative retention time at each shared peak.The finger-print established using the method for building up of Taohong Siwu Tang preparation finger of the present invention, can effectively be characterized the quality of Taohong Siwu Tang preparation, be conducive to that work is instructed to produce, overall monitor drug quality;The method of the present invention has method simplicity, stablizes, precision height, high repeatability and other advantages.

Description

The method for building up and its finger-print of Taohong Siwu Tang preparation finger
Technical field
The invention belongs to drug detection technique fields, are specifically related to a kind of foundation of Taohong Siwu Tang preparation finger Method and its finger-print.
Background technique
Taohong Siwu Tang comes from " Yizong Jinjian gynaecology heart method gist menstruation regulating door " written by Qing Dynasty Wu Qian, by basic Fang Si Object soup (Radix Angelicae Sinensis, Rhizoma Chuanxiong, Rehmannia glutinosa, Radix Paeoniae Alba) plus peach kernel, safflower are formed, and are had the effect of promoting blood circulation, nourishing blood for regulating menstruation, are cured mainly Woman in menstrual period belongs to hemostasis in advance person.Recent study shows that Taohong Siwu Tang has anti-inflammatory, analgesia, improves microcirculation, promotes blood Pipe generates, improves body non-specific immune function, promote union, treat femoral head ischemic necrosis, delay hepatic fibrosis Change process and other effects.
In Chinese medicine tradition medication, decoction is still occupied an leading position, have absorb rapidly, that production is quick, drug effect is powerful is excellent The problems such as point, but because its stability is poor, not easy to maintain, the dose of patient is big, not portable limits its application.Granule exists Take it is the most consistent with traditional decoction in form, on the basis of maintaining decoction advantage, have it is easy to carry, property is stable, It is easy to save, is suitable for the advantages that industrial mass production.
Since the quality of Chinese medicine is very different, complicated component, existing analysis method are difficult to react medicinal material matter comprehensively in addition It measures, content substantially only controls one or two index ingredient in the drug standards of compound Chinese medicinal preparation currently on the market, It is difficult to preferably control drug quality.Traditional Chinese medicine fingerprint is a kind of synthesis, quantifiable identification of means, during it is built upon On the basis of medicine chemical component system research, be mainly used for evaluating the authenticity of Chinese medicine and Chinese materia medica preparation semi-manufactured goods quality, Optimality and stability.Chinese medicine and its preparation are multi-component complex system, therefore evaluate its quality should be using being adapted therewith , the detection method of abundant authentication information can be provided, establishing traditional Chinese medicine fingerprint more will comprehensively reflect Chinese medicine and its system The type and quantity of contained chemical component in agent, and then whole description and evaluation are carried out to drug quality.Therefore Chinese medicine system is established Agent finger-print promotes the modernization of Chinese medicine to be of great significance for improving traditional Chinese medicine quality.
" the Taohong Siwu Tang characteristic spectrum of Different Extraction Method studies [J] Yunnan University of Traditional Chinese Medicine journal, and 2017 (3) " are adopted Map research is done to the Different Extraction Method of Taohong Siwu Tang with wavelength switching method, establishes the HPLC characteristic pattern of Taohong Siwu Tang Spectrum, shares 22 shared peaks, and pointed out to the chemical structure at wherein 5 shared peaks, according to reported in literature, galla turcica Acid, Paeoniflorin are mostly derived from the Radix Paeoniae Alba in prescription, and 5 hydroxymethyl furfural is mostly derived from the glutinous rehmannia in prescription, Sydroxy carthamin A is mostly derived from the safflower in prescription, and ferulic acid is mostly derived from Radix Angelicae Sinensis and Rhizoma Chuanxiong in prescription.But it is not pointed out in prescription in text The characteristic component of peach kernel and the assay ingredient of glutinous rehmannia, and 4,5,18, No. 21 in finger-print disclosed in text are altogether There is peak, peak area is larger, is the representative component in Taohong Siwu Tang, but its chemical structure is not pointed out in text, moreover, fingerprint Map will also calculate similarity compared to characteristic spectrum, give between each component other than the structural information for providing characteristic peak Amount relationship, the product information provided is more comprehensively.
It is disclosed in patent " a kind of detection method of the pharmaceutical preparation of Taohong Siwu Tang of CN 201710780204- " pink The fingerprint spectrum method of Siwu Tang shares 11 common characteristic peaks, and is referred to the chemical structure at wherein 5 shared peaks Recognize, respectively hydroxyl radical carthamin yellow carthamus A, Paeoniflorin, ferulic acid, acteoside, Ligustilide, but does not point out prescription in text In peach kernel characteristic component, and as a compound Chinese medicinal preparation by 6 taste Chinese medicinal compositions, 11 common characteristic peaks are given Chemical information out slightly shows thin.Therefore, method provided by the prior art cannot full and accurate embodiment each group patent medicine comprehensively letter Breath, it is comprehensive as the method not enough science for instructing industrial production to control drug quality.
Summary of the invention
Refer to the technical problem to be solved by the present invention is overcoming the deficiencies of the prior art and provide a kind of Taohong Siwu Tang preparation The method for building up and its finger-print of line map.The fingerprint image established using the method for building up of finger-print of the present invention Spectrum, can characterize whole medicinal material information in Taohong Siwu Tang preparation comprehensively, more comprehensively embody the quality of drug;For referring to Industrial production is led, can preferably guarantee product quality.
The method for building up of Taohong Siwu Tang preparation finger of the present invention, comprising the following steps:
(1) preparation of testing sample solution
It takes Taohong Siwu Tang preparation finely ground, the methanol aqueous solution of concentration expressed in percentage by volume 30% is added and carries out ultrasonic dissolution, The methanol aqueous solution for adding concentration expressed in percentage by volume 30% supplies the weight of less loss, shakes up, and miillpore filter filtration takes filtrate to obtain the final product Testing sample solution;
(2) preparation of reference solution
Take gallic acid, tryptophan, chlorogenic acid, amarogentin, hydroxyl radical carthamin yellow carthamus A, Paeoniflorin, ferulic acid, Mao Rui Flower glucosides and Ligustilide, add methanol to dissolve, solution of every 1ml containing each 20 μ g of reference substance are made, as reference solution;
(3) accurate respectively to draw reference solution and each 5-10 μ l of testing sample solution, inject high performance liquid chromatograph, note Finger-print in record 65-75 minutes;
(4) by the finger-print integrated signal of sample to be tested import Chinese Pharmacopoeia committee " chromatographic fingerprints of Chinese materia medica is similar Degree evaluation system A editions " software;Select in the finger-print of different batches Taohong Siwu Tang preparation existing chromatographic peak as being total to There is peak;Similarity result is calculated with mean value calculation method, and generates standard control finger-print;Calculate the opposite guarantor at each shared peak Stay time and each shared peak relative retention time and the ratio referring to peak relative retention time.
Wherein:
Preferably, the preparation of testing sample solution described in step (1) is: taking the Taohong Siwu Tang granule of different batches Sample, it is finely ground, it takes 0.8g Taohong Siwu Tang granule sample to be placed in stuffed conical flask respectively, concentration expressed in percentage by volume 30% is added Methanol aqueous solution 25ml, close plug, weighed weight, and being ultrasonically treated after ultrasonic treatment, adds concentration expressed in percentage by volume 30% methanol aqueous solution supplies the weight of less loss, shakes up, and miillpore filter (aperture is 0.45 μm) filtration takes filtrate up to be measured Sample solution.
The chromatographic condition of determining fingerprint pattern described in step (3) are as follows:
Chromatographic column: using octadecylsilane chemically bonded silica as filler;
Column temperature: 25-35 DEG C;
Flow velocity: 0.8-1.2ml/min;
Sample volume is 5-10 μ l;
Ultraviolet detection wavelength: 210-250nm, it is preferred that ultraviolet detection wavelength is one in 210nm, 220nm or 250nm Kind.
Mobile phase is any one in following (1), (2), (3) or (4):
(1) 0.02% phosphate aqueous solution of mobile phase A concentration expressed in percentage by volume-Mobile phase B methanol aqueous solution;
(2) 0.05% aqueous formic acid of mobile phase A concentration expressed in percentage by volume-Mobile phase B methanol aqueous solution;
(3) 0.1% aqueous formic acid of mobile phase A concentration expressed in percentage by volume-Mobile phase B methanol aqueous solution;
(4) 0.02% trifluoroacetic acid aqueous solution of mobile phase A concentration expressed in percentage by volume-Mobile phase B methanol aqueous solution.
Type of elution uses gradient elution, and the process of gradient elution is any one in following (1), (2) or (3):
(1) 0~5min, 2% Mobile phase B of concentration expressed in percentage by volume, 5~15min, concentration expressed in percentage by volume 2%-20% mobile phase B, 15~35min, concentration expressed in percentage by volume 20%-28% Mobile phase B, 35~60min, concentration expressed in percentage by volume 28%-80% flowing Phase B, 60~65min, 80% Mobile phase B of concentration expressed in percentage by volume, 65~66min, concentration expressed in percentage by volume 80%-2% Mobile phase B, 66~75min, 2% Mobile phase B of concentration expressed in percentage by volume;
(2) 0~5min, 3% Mobile phase B of concentration expressed in percentage by volume, 5~15min, concentration expressed in percentage by volume 3%-16% mobile phase B, 15~20min, concentration expressed in percentage by volume 16%-25% Mobile phase B, 20~30min, 25% Mobile phase B of concentration expressed in percentage by volume, 30 ~40min, concentration expressed in percentage by volume 25%-40% Mobile phase B, 40~50min, concentration expressed in percentage by volume 40%-80% Mobile phase B, 50~60min, 80% Mobile phase B of concentration expressed in percentage by volume, 60~61min, concentration expressed in percentage by volume 80%-3% Mobile phase B, 61~ 70min, 3% Mobile phase B of concentration expressed in percentage by volume;
(3) 0~5min, 3% Mobile phase B of concentration expressed in percentage by volume, 5~15min, concentration expressed in percentage by volume 3%-15% mobile phase B, 15~20min, concentration expressed in percentage by volume 15%-25% Mobile phase B, 20~30min, 25% Mobile phase B of concentration expressed in percentage by volume, 30 ~40min, concentration expressed in percentage by volume 25%-40% Mobile phase B, 40~55min, concentration expressed in percentage by volume 40%-80% Mobile phase B, 50~60min, 80% Mobile phase B of concentration expressed in percentage by volume, 60~61min, concentration expressed in percentage by volume 80%-3% Mobile phase B, 61~ 70min, 3% Mobile phase B of concentration expressed in percentage by volume.
The preparation method of Taohong Siwu Tang granule described in step (1) is: taking 9 parts of radix rehmanniae recen (wine is washed), Rhizoma Chuanxiong 3 Part, 12 parts of Radix Angelicae Sinensis (wine is washed), 3.78 parts of peach kernel (mud is ground in peeling), 4.5 parts of Radix Paeoniae Alba (parched with wine) and 3 parts of safflower (wine is washed), above six Taste, add water to cook it is secondary, 1 hour every time, for the first time plus the water of whole 12 times of weight of medicine materical crude slice, second plus whole medicine materical crude slice weight 10 Water again, decocting liquid filtration, filtrate merge, and filtrate decompression is concentrated into thick paste, and thick paste is dried under reduced pressure to solid, crushes, is added in right amount Auxiliary material, granulation, whole grain is to get Taohong Siwu Tang granule.
The finger-print include 28 shared peaks, each shared peak relative retention time with referring to peak relative retention time Ratio is respectively as follows:
No. 1 peak relative retention time RRT is 0.16;No. 2 peak relative retention time RRT are 0.22;The opposite reservation at No. 3 peaks Time RRT is 0.24;No. 4 peak relative retention time RRT are 0.27;No. 5 peak relative retention time RRT are 0.33;No. 6 peaks are opposite Retention time RRT is 0.36;No. 7 peak relative retention time RRT are 0.38;No. 8 peak relative retention time RRT are 0.48;No. 9 peaks Relative retention time RRT is 0.54;No. 10 peak relative retention time RRT are 0.57;No. 11 peak relative retention time RRT are 0.58;No. 12 peak relative retention time RRT are 0.65;No. 13 peak relative retention time RRT are 0.66;When No. 14 peaks retain relatively Between RRT be 0.72;No. 15 peak relative retention time RRT are 0.76;No. 16 peak relative retention time RRT are 0.79;No. 17 peak phases It is 0.81 to retention time RRT;No. 18 peak relative retention time RRT are 0.83;No. 19 peak relative retention time RRT are 0.88; No. 20 peak relative retention time RRT are 1.00;No. 21 peak relative retention time RRT are 1.16;No. 22 peak relative retention time RRT It is 1.19;No. 23 peak relative retention time RRT are 1.23;No. 24 peak relative retention time RRT are 1.26;No. 25 peaks are opposite to be retained Time RRT is 1.36;No. 26 peak relative retention time RRT are 1.43;No. 27 peak relative retention time RRT are 1.49;No. 28 peaks Relative retention time RRT is 1.53.Wherein: No. 20 peaks S are referring to peak.
No. 6 peaks are gallic acid in shared peak, and No. 10 peaks are tryptophan, and No. 14 peaks are amarogentin, and No. 15 peaks are green original Acid, No. 19 peaks are hydroxyl radical carthamin yellow carthamus A, and No. 20 peaks are Paeoniflorin, and No. 21 peaks are ferulic acid, and No. 24 peaks are acteoside, No. 28 peaks are Ligustilide.
The present invention establishes the finger-print of Taohong Siwu Tang preparation using high performance liquid chromatography, shares 28 shared peaks, And the chemical structure at wherein 9 shared peaks has been pointed out, whole medicinal material information in Taohong Siwu Tang preparation can be characterized comprehensively, more It can preferably guarantee product quality for instructing industrial production for the quality for comprehensively embodying drug.
Compared with the prior art, the present invention has the following beneficial effects:
(1) finger-print of Taohong Siwu Tang preparation of the present invention shares 28 shared peaks, and wherein peak has been determined The chemical structure at the biggish 9 shared peaks of area ratio, wherein the spy comprising characteristic component amarogentin and glutinous rehmannia derived from peach kernel Ingredient acteoside is levied, finger-print provided by the present invention can embody pink four in a map under Same Wavelength The medicinal material information of object soup whole more comprehensively embodies the quality of drug, and the method relative to wavelength switching, institute of the present invention The method of offer is more simple and easy to do.
(2) finger-print of Taohong Siwu Tang preparation of the present invention, can more fully react drug quality, work as drug When quality occurs problem or adverse reaction occurs, can more accurately confirm which taste medicinal material there is a problem in prescription, to guidance Industrial production control drug quality is more significant, and finger-print information is more comprehensively, more full and accurate, can preferably guarantee product matter Amount.
(3) method for building up of the finger-print of Taohong Siwu Tang preparation of the present invention has easy, stable, accurate The advantages of degree height, favorable reproducibility.
Detailed description of the invention
Fig. 1 is 18010201-18010216 batches of sample finger-prints and standard control finger-prints;
Fig. 2 is reference solution finger-print;
Fig. 3 is 18010201 batches of test article fingerprints;
Fig. 4 is 18010201 stability experiment finger-prints;
Fig. 5 is 18010201 Precision Experiment finger-prints;
Fig. 6 is 18010201 repeated experiment finger-prints;
In figure: 1, gallic acid;2, tryptophan;3, amarogentin;4, chlorogenic acid;5, hydroxyl radical carthamin yellow carthamus A;6, Chinese herbaceous peony Glycosides;7, ferulic acid B;8, acteoside A;9, Ligustilide;S1,18010201 crowdes;S2,18010202 crowdes;S318010203 Batch,;S4,18010204 crowdes;S5,18010205 crowdes;S6,18010206 crowdes;S7,18010207 crowdes;S8,18010208 crowdes;S9, 18010209 batches;S10,18010210 crowdes;S11,18010211 crowdes;S12,18010212 crowdes;S13,18010213 crowdes;S14, 18010214 batches;S15,18010215 crowdes;S16,18010216 crowdes;R, reference fingerprint.
Specific embodiment
The invention will be further described with reference to embodiments.
1, the preparation of Taohong Siwu Tang preparation
Prescription medicine totally 16 batches are bought from national main Chinese medicinal materials producing region and Genuine producing area respectively, place of production information is shown in Table 1.
Taohong Siwu Tang preparation of the present invention the preparation method is as follows: taking radix rehmanniae recen (wine is washed) 9g, Rhizoma Chuanxiong 3g, Radix Angelicae Sinensis (wine is washed) 12g, peach kernel 3.78g, Radix Paeoniae Alba (parched with wine) 4.5g, safflower (wine is washed) 3g, the above Six-element adds water to cook secondary, and 1 is small every time When, add the water of whole 12 times of weight of medicine materical crude slice for the first time, for the second time plus the water of whole 10 times of weight of medicine materical crude slice, decocting liquid filter, and filtrate is closed And filtrate decompression is concentrated into thick paste, thick paste is dried under reduced pressure to solid, crushes, and appropriate amount of auxiliary materials is added, granulation, whole grain is to get pink Siwu Tang granule.
Medicinal material is taken to prepare Taohong Siwu Tang particle by the number of medicinal material listed by table 1, sampling method is to take Radix Paeoniae Alba No. 1, safflower 1 Number, peach kernel 1, glutinous rehmannia No. 1, No. 1 Radix Angelicae Sinensis 1, Rhizoma Chuanxiong medicinal material prepare Taohong Siwu Tang particle, lot number 18010201;It takes white No. 2 Chinese herbaceous peony 2, safflower 2, peach kernel 2, glutinous rehmannia No. 2, Radix Angelicae Sinensis 2, Rhizoma Chuanxiong medicinal materials prepare Taohong Siwu Tang particle, and lot number is 18010202, and so on.
The Taohong Siwu Tang particle of preparation, lot number 18010201-18010216.18010201 batches of numbers are S1, 18010202 batches of numbers are S2, and so on, 18010216 batches of numbers are S16.
Embodiment 1
The method for building up of Taohong Siwu Tang preparation finger described in embodiment 1, comprising the following steps:
1, instrument and reagent
High performance liquid chromatograph (Agilent 1260), assay balance (METTLER TOLEDO XS/205DU), ultrasound are clear Washing machine (KQ-5200E).
Reagent: methanol is chromatographically pure, and water is ultrapure water;Other reagents are that analysis is pure.Gallic acid, color ammonia in object of reference During acid, amarogentin, chlorogenic acid, hydroxyl radical carthamin yellow carthamus A, Paeoniflorin, ferulic acid, acteoside, Ligustilide are purchased from State's food and medicine examines and determine research institute.
For reagent: Taohong Siwu Tang particle (lot number: 18010201-18010216)
2, chromatographic condition: using octadecylsilane chemically bonded silica as filler (Agilent 5TC-C18,4.6*250mm, 5 μm), using 0.02% phosphate aqueous solution as mobile phase A, using methanol as Mobile phase B, condition of gradient elution is 0~5min, volume hundred Divide 3% Mobile phase B of concentration, 5~15min, concentration expressed in percentage by volume 3%-16% Mobile phase B, 15~20min, concentration expressed in percentage by volume 16%-25% Mobile phase B, 20~30min, 25% Mobile phase B of concentration expressed in percentage by volume, 30~40min, concentration expressed in percentage by volume 25%-40% Mobile phase B, 40~50min, concentration expressed in percentage by volume 40%-80% Mobile phase B, 50~60min, volume basis are dense Spend 80% Mobile phase B, 60~61min, concentration expressed in percentage by volume 80%-3% Mobile phase B, 61~70min, concentration expressed in percentage by volume 3% Mobile phase B.
Flow velocity is 1.0ml/min;35 DEG C of column temperature;Detection wavelength is 220nm.Number of theoretical plate should not be low by the calculating of Paeoniflorin peak In 3000.
3, the preparation of reference solution: take gallic acid, tryptophan, chlorogenic acid, amarogentin, hydroxyl radical carthamin yellow carthamus A, Paeoniflorin, ferulic acid, acteoside and Ligustilide, add methanol to dissolve, and solution of every 1ml containing each 20 μ g of reference substance is made, As reference solution.
4, the preparation of testing sample solution: taking Taohong Siwu Tang particle, finely ground, takes about 0.8g, accurately weighed, sets tool plug cone In shape bottle, 30% methanol 25ml of concentration expressed in percentage by volume, close plug, weighed weight, with 30% methanol benefit after ultrasonic treatment is added in precision The weight of sufficient less loss shakes up filtration, take subsequent filtrate to get.
5, measuring method: it is accurate respectively to draw reference solution and each 10 μ l of test solution, inject high performance liquid chromatograph In, measurement records 70 minutes chromatograms.
Obtained finger-print includes 28 shared peaks, each peak relative retention time are as follows:
No. 1 peak 5.821min;No. 2 peak 7.876min;No. 3 peak 8.592min;No. 4 peak 9.367min;No. 5 peaks 11.764min;No. 6 peak 12.890min;No. 7 peak 13.497min;No. 8 peaks 17.126;No. 9 peaks 19.113;No. 10 peaks 20.122min;No. 11 peak 20.527min;No. 12 peak 22.968min;No. 13 peak 23.485min;No. 14 peak 25.564min;15 Number peak 26.739min;No. 16 peak 27.844min;No. 17 peak 28.445min;No. 18 peak 29.456min;No. 19 peaks 31.171min;No. 20 peak 35.329min;No. 21 peak 40.999min;No. 22 peak 42.096min;No. 23 peak 43.378min;24 Number peak 44.442min;No. 25 peak 48.220min;No. 26 peak 50.417min;No. 27 peak 52.546min;No. 28 peaks 54.059min.No. 20 peaks are referring to peak.
Each peak relative retention time is respectively as follows: with referring to peak relative retention time ratio
No. 1 peak relative retention time RRT is 0.16;No. 2 peak relative retention time RRT are 0.22;The opposite reservation at No. 3 peaks Time RRT is 0.24;No. 4 peak relative retention time RRT are 0.27;No. 5 peak relative retention time RRT are 0.33;No. 6 peaks are opposite Retention time RRT is 0.36;No. 7 peak relative retention time RRT are 0.38;No. 8 peak relative retention time RRT are 0.48;No. 9 peaks Relative retention time RRT is 0.54;No. 10 peak relative retention time RRT are 0.57;No. 11 peak relative retention time RRT are 0.58;No. 12 peak relative retention time RRT are 0.65;No. 13 peak relative retention time RRT are 0.66;When No. 14 peaks retain relatively Between RRT be 0.72;No. 15 peak relative retention time RRT are 0.76;No. 16 peak relative retention time RRT are 0.79;No. 17 peak phases It is 0.81 to retention time RRT;No. 18 peak relative retention time RRT are 0.83;No. 19 peak relative retention time RRT are 0.88; No. 20 peak relative retention time RRT are 1.00;No. 21 peak relative retention time RRT are 1.16;No. 22 peak relative retention time RRT It is 1.19;No. 23 peak relative retention time RRT are 1.23;No. 24 peak relative retention time RRT are 1.26;No. 25 peaks are opposite to be retained Time RRT is 1.36;No. 26 peak relative retention time RRT are 1.43;No. 27 peak relative retention time RRT are 1.49;No. 28 peaks Relative retention time RRT is 1.53.Wherein: No. 20 peaks S are the chromatographic peaks of object of reference.Characteristic spectrum described in embodiment 1 is shown in attached Fig. 1.
Wherein: No. 6 peaks are gallic acid in shared peak, and No. 10 peaks are tryptophan, and No. 14 peaks are amarogentin, and No. 15 peaks are Chlorogenic acid, No. 19 peaks are hydroxyl radical carthamin yellow carthamus A, and No. 20 peaks are Paeoniflorin, and No. 21 peaks are ferulic acid, and No. 24 peaks are verbascose Glycosides, No. 28 peaks are Ligustilide.See attached drawing 2.
The corresponding No. 6 shared peaks in No. 1 peak in Fig. 2, are gallic acid;The corresponding No. 10 shared peaks in No. 2 peaks, are tryptophan;No. 3 peaks Corresponding No. 14 shared peaks are amarogentin;The corresponding No. 15 shared peaks in No. 4 peaks, are chlorogenic acid;The corresponding No. 19 shared peaks in No. 5 peaks are Hydroxyl radical carthamin yellow carthamus A;The corresponding No. 20 shared peaks in No. 6 peaks, are Paeoniflorin;The corresponding No. 21 shared peaks in No. 7 peaks, are ferulic acid;No. 8 No. 24 shared peaks are coped at peak, are acteoside;The corresponding 28 shared peaks in No. 9 peaks, are Ligustilide.
Integrated signal is imported to " similarity evaluation A editions " software of Chinese Pharmacopoeia committee, with S1 is to calculate to obtain similarity result referring to spectrogram by mean value method, and generate standard control finger-print (RFP), see Fig. 1, phase It the results are shown in Table 2 like degree.Similarity is substandard product less than 0.90, carries out quality evaluation to 16 batches of samples.
18010201 batches of numbers are S1, and 18010202 batches of numbers are S2, and so on, 18010216 batches of numbers are S16.
2 16 batches of sample finger-prints of table are compared with standard control fingerprint similarity
Number Similarity
S1 0.987
S2 0.986
S3 0.968
S4 0.963
S5 0.971
S6 0.972
S7 0.926
S8 0.984
S9 0.978
S10 0.987
S11 0.986
S12 0.968
S13 0.963
S14 0.972
S15 0.926
S16 0.984
The above result shows that 18010201-18010216 batches of samples are qualified products.
Embodiment 2
The method for building up of Taohong Siwu Tang preparation finger as described in example 2, comprising the following steps:
1. instrument and reagent
High performance liquid chromatograph (Agilent 1260), assay balance (METTLER TOLEDO XS/205DU), ultrasound are clear Washing machine (KQ-5200E).
Reagent: methanol is chromatographically pure, and water is ultrapure water;Other reagents are that analysis is pure.Gallic acid, color ammonia in object of reference During acid, amarogentin, chlorogenic acid, hydroxyl radical carthamin yellow carthamus A, Paeoniflorin, ferulic acid, acteoside, Ligustilide are purchased from State's food and medicine examines and determine research institute.
For reagent: Taohong Siwu Tang particle (lot number: 18010201-18010216).
2. chromatographic condition: using octadecylsilane chemically bonded silica as filler (Agilent ZORBAX SB-C18,4.6 × 250mm, 5 μm), using 0.05% aqueous formic acid as mobile phase A, using methanol as Mobile phase B, condition of gradient elution is 0~5min, 2% Mobile phase B, 5~15min, 2%-20% Mobile phase B, 15~35min, 20%-28% Mobile phase B, 35~60min, 28%-80% Mobile phase B, 60~65min, 80% Mobile phase B, 65~66min, 80%-2% Mobile phase B, 66~75min, 2% Mobile phase B.Flow velocity is 0.8ml per minute;25 DEG C of column temperature;Detection wavelength is 210nm.Number of theoretical plate is calculated by Paeoniflorin peak 3000 should be not less than.
3. the preparation of reference solution: take gallic acid, tryptophan, chlorogenic acid, amarogentin, hydroxyl radical carthamin yellow carthamus A, Paeoniflorin, ferulic acid, acteoside and Ligustilide, add methanol to dissolve, and solution of every 1ml containing each 20 μ g of reference substance is made, As reference solution.
4. the preparation of test solution: Taohong Siwu Tang particle is taken, it is finely ground, about 0.8g is taken, it is accurately weighed, set tool plug taper In bottle, 30% methanol 25ml, close plug is added in precision, and weighed weight is supplied the weight of less loss after ultrasonic treatment with 30% methanol, shaken Even filtration, take subsequent filtrate to get.
5. measuring method: it is accurate respectively to draw reference solution and each 8 μ l of test solution, inject high performance liquid chromatograph In, measurement records 75 minutes chromatograms.
Obtained finger-print includes 28 shared peaks, each peak relative retention time are as follows:
No. 1 peak 5.075min;No. 2 peak 6.028min;No. 3 peak 6.284min;No. 4 peak 7.716min;No. 5 peaks 9.006min;No. 6 peak 10.066min;No. 7 peak 12.205min;No. 8 peaks 12.319;No. 9 peaks 18.790;No. 10 peaks 18.875min;No. 11 peak 22.366min;No. 12 peak 24.867min;No. 13 peak 26.345min;No. 14 peak 27.662min;15 Number peak 28.265min;No. 16 peak 28.848min;No. 17 peak 29.545min;No. 18 peak 31.201min;No. 19 peaks 34.586min;No. 20 peak 35.209min;No. 21 peak 41.990min;No. 22 peak 43.165min;No. 23 peak 44.028min;24 Number peak 48.425min;No. 25 peak 50.448min;No. 26 peak 50.882min;No. 27 peak 57.589min;No. 28 peaks 60.325min.No. 20 peaks are referring to peak.
Each peak relative retention time is respectively as follows: with referring to peak relative retention time ratio
No. 1 peak relative retention time RRT is 0.14;No. 2 peak relative retention time RRT are 0.17;The opposite reservation at No. 3 peaks Time RRT is 0.18;No. 4 peak relative retention time RRT are 0.22;No. 5 peak relative retention time RRT are 0.26;No. 6 peaks are opposite Retention time RRT is 0.29;No. 7 peak relative retention time RRT are 0.35;No. 8 peak relative retention time RRT are 0.35;No. 9 peaks Relative retention time RRT is 0.53;No. 10 peak relative retention time RRT are 0.54;No. 11 peak relative retention time RRT are 0.64;No. 12 peak relative retention time RRT are 0.71;No. 13 peak relative retention time RRT are 0.75;When No. 14 peaks retain relatively Between RRT be 0.79;No. 15 peak relative retention time RRT are 0.80;No. 16 peak relative retention time RRT are 0.82;No. 17 peak phases It is 0.84 to retention time RRT;No. 18 peak relative retention time RRT are 0.89;No. 19 peak relative retention time RRT are 0.98; No. 20 peak relative retention time RRT are 1.00;No. 21 peak relative retention time RRT are 1.19;No. 22 peak relative retention time RRT It is 1.23;No. 23 peak relative retention time RRT are 1.25;No. 24 peak relative retention time RRT are 1.38;No. 25 peaks are opposite to be retained Time RRT is 1.43;No. 26 peak relative retention time RRT are 1.45;No. 27 peak relative retention time RRT are 1.64;No. 28 peaks Relative retention time RRT is 1.71.Wherein: No. 20 peaks S are the chromatographic peaks of object of reference.
Wherein: No. 7 peaks are gallic acid in shared peak, and No. 10 peaks are tryptophan, and No. 12 peaks are amarogentin, and No. 13 peaks are Chlorogenic acid, No. 18 peaks are hydroxyl radical carthamin yellow carthamus A, and No. 20 peaks are Paeoniflorin, and No. 21 peaks are ferulic acid, and No. 23 peaks are verbascose Glycosides, No. 28 peaks are Ligustilide.
6. similarity result: integrated signal is imported to " the chromatographic fingerprints of Chinese materia medica similarity evaluation system of Chinese Pharmacopoeia committee System A editions " software is to calculate to obtain similarity result by mean value method, similarity result is shown in Table 3 referring to spectrogram with S1.Similarity is small It is substandard product in 0.90, quality evaluation is carried out to 16 batches of samples.
18010201 batches of numbers are S1, and 18010202 batches of numbers are S2, and so on, 18010216 batches of numbers are S16.
3 16 batches of sample finger-prints of table are compared with standard control fingerprint similarity
Number Similarity
S1 0.983
S2 0.979
S3 0.975
S4 0.977
S5 0.982
S6 0.982
S7 0.973
S8 0.983
S9 0.981
S10 0.950
S11 0.982
S12 0.988
S13 0.983
S14 0.966
S15 0.980
S16 0.981
The above result shows that 18010201-18010216 batches of samples are qualified products.
Embodiment 3
The method for building up of Taohong Siwu Tang preparation finger described in embodiment 3, comprising the following steps:
1. instrument and reagent
High performance liquid chromatograph (Agilent 1260), assay balance (METTLER TOLEDO XS/205DU), ultrasound are clear Washing machine (KQ-5200E).
Reagent: methanol is chromatographically pure, and water is ultrapure water;Other reagents are that analysis is pure.Gallic acid, color ammonia in object of reference During acid, amarogentin, chlorogenic acid, hydroxyl radical carthamin yellow carthamus A, Paeoniflorin, ferulic acid, acteoside, Ligustilide are purchased from State's food and medicine examines and determine research institute.
For reagent: Taohong Siwu Tang particle (lot number: 18010201-18010216).
2. chromatographic condition: using octadecylsilane chemically bonded silica as filler (Cosmosil 5C18-AR-II, 4.6 × 250mm, 5 μm), using 0.1% aqueous formic acid as mobile phase A, using methanol as Mobile phase B, condition of gradient elution is 0~5min, 3%B, 5~15min, 3%-16% Mobile phase B, 15~20min, 16%-25% Mobile phase B, 20~30min, 25% mobile phase B, 30~40min, 25%-40% Mobile phase B, 40~50min, 40%-80% Mobile phase B, 50~60min, 80% mobile phase B, 60~61min, 80%-3% Mobile phase B, 61~70min, 3% Mobile phase B.Flow velocity is 1.2ml/min per minute;Column temperature 35 ℃;Detection wavelength is 250nm.Number of theoretical plate is calculated by Paeoniflorin peak should be not less than 3000.
3. the preparation of reference solution: take gallic acid, tryptophan, chlorogenic acid, amarogentin, hydroxyl radical carthamin yellow carthamus A, Paeoniflorin, ferulic acid, acteoside and Ligustilide, add methanol to dissolve, and every 1ml methanol is made containing the molten of each 20 μ g of reference substance Liquid, as reference solution.
4. the preparation of test solution: Taohong Siwu Tang particle is taken, it is finely ground, about 0.8g is taken, it is accurately weighed, set tool plug taper In bottle, 30% methanol 25ml, close plug is added in precision, and weighed weight is supplied the weight of less loss after ultrasonic treatment with 30% methanol, shaken Even filtration, take subsequent filtrate to get.
5. measuring method: it is accurate respectively to draw reference solution and each 10 μ l of test solution, inject high performance liquid chromatograph In, measurement records 70 minutes chromatograms.
Obtained finger-print includes 28 shared peaks, each peak relative retention time are as follows:
No. 1 peak 5.678min;No. 2 peak 7.536min;No. 3 peak 8.063min;No. 4 peak 9.078min;No. 5 peaks 11.536min;No. 6 peak 12.590min;No. 7 peak 13.197min;No. 8 peaks 16.923;No. 9 peaks 19.113;No. 10 peaks 19.853min;No. 11 peak 20.227min;No. 12 peak 22.668min;No. 13 peak 23.185min;No. 14 peak 25.278min;15 Number peak 26.459min;No. 16 peak 27.522min;No. 17 peak 28.145min;No. 18 peak 29.156min;No. 19 peaks 30.636min;No. 20 peak 35.029min;No. 21 peak 40.796min;No. 22 peak 41.036min;No. 23 peak 43.358min;24 Number peak 44.402min;No. 25 peak 47.920min;No. 26 peak 50.117min;No. 27 peak 52.036min;No. 28 peaks 54.369min.No. 20 peaks are referring to peak.
Each peak relative retention time is respectively as follows: with referring to peak relative retention time ratio
No. 1 peak relative retention time RRT is 0.16;No. 2 peak relative retention time RRT are 0.22;The opposite reservation at No. 3 peaks Time RRT is 0.23;No. 4 peak relative retention time RRT are 0.27;No. 5 peak relative retention time RRT are 0.33;No. 6 peaks are opposite Retention time RRT is 0.36;No. 7 peak relative retention time RRT are 0.38;No. 8 peak relative retention time RRT are 0.48;No. 9 peaks Relative retention time RRT is 0.55;No. 10 peak relative retention time RRT are 0.57;No. 11 peak relative retention time RRT are 0.58;No. 12 peak relative retention time RRT are 0.65;No. 13 peak relative retention time RRT are 0.66;When No. 14 peaks retain relatively Between RRT be 0.72;No. 15 peak relative retention time RRT are 0.76;No. 16 peak relative retention time RRT are 0.79;No. 17 peak phases It is 0.80 to retention time RRT;No. 18 peak relative retention time RRT are 0.83;No. 19 peak relative retention time RRT are 0.87; No. 20 peak relative retention time RRT are 1.00;No. 21 peak relative retention time RRT are 1.16;No. 22 peak relative retention time RRT It is 1.17;No. 23 peak relative retention time RRT are 1.24;No. 24 peak relative retention time RRT are 1.27;No. 25 peaks are opposite to be retained Time RRT is 1.37;No. 26 peak relative retention time RRT are 1.43;No. 27 peak relative retention time RRT are 1.49;No. 28 peaks Relative retention time RRT is 1.55.Wherein: No. 20 peaks S are the chromatographic peaks of object of reference.
Wherein: No. 6 peaks are gallic acid in shared peak, and No. 10 peaks are tryptophan, and No. 14 peaks are amarogentin, and No. 15 peaks are Chlorogenic acid, No. 19 peaks are hydroxyl radical carthamin yellow carthamus A, and No. 20 peaks are Paeoniflorin, and No. 21 peaks are ferulic acid, and No. 24 peaks are verbascose Glycosides, No. 28 peaks are Ligustilide.
6. similarity result: integrated signal is imported to " the chromatographic fingerprints of Chinese materia medica similarity evaluation system of Chinese Pharmacopoeia committee System A editions " software is to calculate to obtain similarity result by mean value method, similarity result is shown in Table 4 referring to spectrogram with S1.Similarity is small It is substandard product in 0.90, quality evaluation is carried out to 16 batches of samples.
18010201 batches of numbers are S1, and 18010202 batches of numbers are S2, and so on, 18010216 batches of numbers are S16.
4 16 batches of sample finger-prints of table are compared with standard control fingerprint similarity
Number Similarity
S1 0.972
S2 0.987
S3 0.960
S4 0.983
S5 0.968
S6 0.964
S7 0.975
S8 0.973
S9 0.970
S10 0.975
S11 0.959
S12 0.984
S13 0.969
S14 0.922
S15 0.980
S16 0.978
The above result shows that 18010201-18010216 batches of samples are qualified products.
Embodiment 4
The method for building up of Taohong Siwu Tang preparation finger as described in example 4, comprising the following steps:
1. instrument and reagent
High performance liquid chromatograph (Agilent 1260), assay balance (METTLER TOLEDO XS/205DU), ultrasound are clear Washing machine (KQ-5200E).
Reagent: methanol is chromatographically pure, and water is ultrapure water;Other reagents are that analysis is pure.Gallic acid, color ammonia in object of reference Acid, amarogentin, chlorogenic acid, Sydroxy carthamin, Paeoniflorin, ferulic acid, acteoside, Ligustilide are purchased from China Food and medicine examines and determine research institute.
Reagent: Taohong Siwu Tang particle (lot number: 18010201-18010216).
2. chromatographic condition: using octadecylsilane chemically bonded silica as filler (Agilent 5TC-C18,4.6 × 250mm, 5 μm), using 0.02% trifluoroacetic acid aqueous solution as mobile phase A, using methanol as Mobile phase B, condition of gradient elution is 0~5min, 3% Mobile phase B, 5~15min, 3%-15% Mobile phase B, 15~20min, 15%-25% Mobile phase B, 20~30min, 25% Mobile phase B, 30~40min, 25%-40% Mobile phase B, 40~50min, 40%-80% Mobile phase B, 50~60min, 80% Mobile phase B, 60~61min, 80%-3% Mobile phase B, 61~70min, 3% Mobile phase B.Flow velocity is 1.0ml/min per minute; 35 DEG C of column temperature;Detection wavelength is 220nm.Number of theoretical plate is calculated by Paeoniflorin peak should be not less than 3000.
3. the preparation of reference solution: take gallic acid, tryptophan, chlorogenic acid, amarogentin, hydroxyl radical carthamin yellow carthamus A, Paeoniflorin, ferulic acid, acteoside and Ligustilide, add methanol to dissolve, and solution of every 1ml containing each 20 μ g of reference substance is made, As reference solution.
4. the preparation of test solution: Taohong Siwu Tang particle is taken, it is finely ground, about 0.8g is taken, it is accurately weighed, set tool plug taper In bottle, 30% methanol 25ml, close plug is added in precision, and weighed weight is supplied the weight of less loss after ultrasonic treatment with 30% methanol, shaken Even filtration, take subsequent filtrate to get.
5. measuring method: it is accurate respectively to draw reference solution and each 5 μ l of test solution, inject high performance liquid chromatograph In, measurement records 70 minutes chromatograms.
Obtained finger-print includes 28 shared peaks, each peak relative retention time are as follows:
No. 1 peak 5.268min;No. 2 peak 7.036min;No. 3 peak 7.563min;No. 4 peak 8.578min;No. 5 peaks 11.636min;No. 6 peak 12.031min;No. 7 peak 12.697min;No. 8 peaks 16.636;No. 9 peaks 18.613;No. 10 peaks 19.365min;No. 11 peak 20.072min;No. 12 peak 22.168min;No. 13 peak 22.685min;No. 14 peak 24.768min;15 Number peak 25.959min;No. 16 peak 27.024min;No. 17 peak 27.645min;No. 18 peak 28.636min;No. 19 peaks 30.179min;No. 20 peak 35.339min;No. 21 peak 40.296min;No. 22 peak 40.536min;No. 23 peak 42.858min;24 Number peak 43.956min;No. 25 peak 47.63min;No. 26 peak 49.617min;No. 27 peak 51.798min;No. 28 peak 53.863min. No. 20 peaks are referring to peak.
Each peak relative retention time is respectively as follows: with referring to peak relative retention time ratio
No. 1 peak relative retention time RRT is 0.15;No. 2 peak relative retention time RRT are 0.20;The opposite reservation at No. 3 peaks Time RRT is 0.21;No. 4 peak relative retention time RRT are 0.24;No. 5 peak relative retention time RRT are 0.33;No. 6 peaks are opposite Retention time RRT is 0.34;No. 7 peak relative retention time RRT are 0.36;No. 8 peak relative retention time RRT are 0.47;No. 9 peaks Relative retention time RRT is 0.53;No. 10 peak relative retention time RRT are 0.55;No. 11 peak relative retention time RRT are 0.57;No. 12 peak relative retention time RRT are 0.63;No. 13 peak relative retention time RRT are 0.64;When No. 14 peaks retain relatively Between RRT be 0.70;No. 15 peak relative retention time RRT are 0.73;No. 16 peak relative retention time RRT are 0.76;No. 17 peak phases It is 0.78 to retention time RRT;No. 18 peak relative retention time RRT are 0.81;No. 19 peak relative retention time RRT are 0.85; No. 20 peak relative retention time RRT are 1.00;No. 21 peak relative retention time RRT are 1.14;No. 22 peak relative retention time RRT It is 1.15;No. 23 peak relative retention time RRT are 1.21;No. 24 peak relative retention time RRT are 1.24;No. 25 peaks are opposite to be retained Time RRT is 1.35;No. 26 peak relative retention time RRT are 1.40;No. 27 peak relative retention time RRT are 1.47;No. 28 peaks Relative retention time RRT is 1.52.Wherein: No. 20 peaks S are the chromatographic peaks of object of reference.
Wherein: No. 6 peaks are gallic acid in shared peak, and No. 10 peaks are tryptophan, and No. 14 peaks are amarogentin, and No. 15 peaks are Chlorogenic acid, No. 19 peaks are hydroxyl radical carthamin yellow carthamus A, and No. 20 peaks are Paeoniflorin, and No. 21 peaks are ferulic acid, and No. 24 peaks are verbascose Glycosides, No. 28 peaks are Ligustilide.
6. similarity result: integrated signal is imported to " the chromatographic fingerprints of Chinese materia medica similarity evaluation system of Chinese Pharmacopoeia committee System A editions " software is to calculate to obtain similarity result by mean value method, similarity result is shown in Table 5 referring to spectrogram with S1.Similarity is small It is substandard product in 0.90, quality evaluation is carried out to 16 batches of samples.
18010201 batches of numbers are S1, and 18010202 batches of numbers are S2, and so on, 18010216 batches of numbers are S16.
5 16 batches of sample finger-prints of table are compared with standard control fingerprint similarity
Number Similarity
S1 0.987
S2 0.972
S3 0.990
S4 0.964
S5 0.983
S6 0.971
S7 0.977
S8 0.972
S9 0.980
S10 0.963
S11 0.976
S12 0.979
S13 0.963
S14 0.968
S15 0.981
S16 0.968
The above result shows that 18010201-18010216 batches of samples are qualified products.
Taohong Siwu Tang preparation finger methodological study
1. stability test
Test solution (lot number 18010201) is taken, test solution is prepared by the method in embodiment 1 and is examined It surveys, respectively at 0,2h, 4h, 8h, 12h, for 24 hours, sample introduction is analyzed by 48h, investigates the relative retention time of main chromatographic peak and with respect to peak The consistency of area, the results are shown in Table 6, Fig. 4.
6 stability similarity of table
Test solution is placed at room temperature for 48 hours, and fingerprint similarity is all larger than 0.95, shows test solution 48 Hour internal stability is good.
2. Precision Experiment
Test solution (lot number 18010201) is taken, test solution is prepared by the method in embodiment 1 and is detected, Continuous sample introduction 6 times, the relative retention time of main chromatographic peak and the consistency of relative peak area are investigated, the results are shown in Table 7, Fig. 5.
7 precision similarity of table
Number Similarity
S1 1.000
S2 1.000
S3 1.000
S4 1.000
S5 1.000
S6 1.000
Test solution continuous sample introduction 6 times, fingerprint similarity is all larger than 0.95, shows that method precision is good.
3. repeated experiment
6 parts of test solution (lot number 18010201) is taken, prepare test solution by the method in embodiment 1 and is carried out Detection, investigates the relative retention time of main chromatographic peak and the consistency of relative peak area, the results are shown in Table 8, Fig. 6.
8 stability similarity of table
Number Similarity
S1 1.000
S2 0.999
S3 1.000
S4 0.999
S5 1.000
S6 1.000
6 parts of test solution fingerprint similarities are all larger than 0.95, show that method repeatability is good.

Claims (9)

1. a kind of method for building up of Taohong Siwu Tang preparation finger, it is characterised in that: the following steps are included:
(1) preparation of testing sample solution
It takes Taohong Siwu Tang preparation finely ground, the methanol aqueous solution of concentration expressed in percentage by volume 30% is added and carries out ultrasonic dissolution, then plus The methanol aqueous solution for entering concentration expressed in percentage by volume 30% supplies the weight of less loss, shakes up, and miillpore filter filtration takes filtrate up to be measured Sample solution;
(2) preparation of reference solution
Take gallic acid, tryptophan, chlorogenic acid, amarogentin, hydroxyl radical carthamin yellow carthamus A, Paeoniflorin, ferulic acid, verbascose Glycosides and Ligustilide, add methanol to dissolve, and solution of every 1ml containing each 20 μ g of reference substance are made, as reference solution;
(3) accurate respectively to draw reference solution and each 5-10 μ l of testing sample solution, inject high performance liquid chromatograph, record Finger-print in 65-75 minutes;
(4) by the finger-print integrated signal of sample to be tested import Chinese Pharmacopoeia committee " chromatographic fingerprints of Chinese materia medica similarity is commented Valence system A editions " software;Select in the finger-print of different batches Taohong Siwu Tang preparation existing chromatographic peak as sharing Peak;Similarity result is calculated with mean value calculation method, and generates standard control finger-print;Calculate the opposite reservation at each shared peak Time and each shared peak relative retention time and the ratio referring to peak relative retention time.
2. the method for building up of Taohong Siwu Tang preparation finger according to claim 1, it is characterised in that: step (1) The preparation of the testing sample solution is: the Taohong Siwu Tang granule sample of different batches is taken, it is finely ground, and 0.8g peach is taken respectively Red Siwu Tang granule sample is placed in stuffed conical flask, the methanol aqueous solution 25ml of addition concentration expressed in percentage by volume 30%, close plug, Weighed weight, and be ultrasonically treated, after ultrasonic treatment, the methanol aqueous solution for adding concentration expressed in percentage by volume 30% supplies less loss Weight, shake up, miillpore filter filtration, take filtrate up to testing sample solution.
3. the method for building up of Taohong Siwu Tang preparation finger according to claim 1, it is characterised in that: step (3) Described in determining fingerprint pattern chromatographic condition are as follows:
Chromatographic column: using octadecylsilane chemically bonded silica as filler;
Column temperature: 25-35 DEG C;
Flow velocity: 0.8-1.2ml/min;
Sample volume is 5-10 μ l;
Ultraviolet detection wavelength: 210-250nm.
4. the method for building up of Taohong Siwu Tang preparation finger according to claim 3, it is characterised in that: ultraviolet detection Wavelength is one of 210nm, 220nm or 250nm.
5. the method for building up of Taohong Siwu Tang preparation finger according to claim 3, it is characterised in that: mobile phase is Any one in (1), (2), (3) or (4) below:
(1) 0.02% phosphate aqueous solution of mobile phase A concentration expressed in percentage by volume-Mobile phase B methanol aqueous solution;
(2) 0.05% aqueous formic acid of mobile phase A concentration expressed in percentage by volume-Mobile phase B methanol aqueous solution;
(3) 0.1% aqueous formic acid of mobile phase A concentration expressed in percentage by volume-Mobile phase B methanol aqueous solution;
(4) 0.02% trifluoroacetic acid aqueous solution of mobile phase A concentration expressed in percentage by volume-Mobile phase B methanol aqueous solution.
6. the method for building up of Taohong Siwu Tang preparation finger according to claim 3, it is characterised in that: type of elution Using gradient elution, the process of gradient elution is any one in following (1), (2) or (3):
(1) 0~5min, 2% Mobile phase B of concentration expressed in percentage by volume, 5~15min, concentration expressed in percentage by volume 2%-20% Mobile phase B, 15 ~35min, concentration expressed in percentage by volume 20%-28% Mobile phase B, 35~60min, concentration expressed in percentage by volume 28%-80% Mobile phase B, 60~65min, 80% Mobile phase B of concentration expressed in percentage by volume, 65~66min, concentration expressed in percentage by volume 80%-2% Mobile phase B, 66~ 75min, 2% Mobile phase B of concentration expressed in percentage by volume;
(2) 0~5min, 3% Mobile phase B of concentration expressed in percentage by volume, 5~15min, concentration expressed in percentage by volume 3%-16% Mobile phase B, 15 ~20min, concentration expressed in percentage by volume 16%-25% Mobile phase B, 20~30min, 25% Mobile phase B of concentration expressed in percentage by volume, 30~ 40min, concentration expressed in percentage by volume 25%-40% Mobile phase B, 40~50min, concentration expressed in percentage by volume 40%-80% Mobile phase B, 50 ~60min, 80% Mobile phase B of concentration expressed in percentage by volume, 60~61min, concentration expressed in percentage by volume 80%-3% Mobile phase B, 61~ 70min, 3% Mobile phase B of concentration expressed in percentage by volume;
(3) 0~5min, 3% Mobile phase B of concentration expressed in percentage by volume, 5~15min, concentration expressed in percentage by volume 3%-15% Mobile phase B, 15 ~20min, concentration expressed in percentage by volume 15%-25% Mobile phase B, 20~30min, 25% Mobile phase B of concentration expressed in percentage by volume, 30~ 40min, concentration expressed in percentage by volume 25%-40% Mobile phase B, 40~55min, concentration expressed in percentage by volume 40%-80% Mobile phase B, 50 ~60min, 80% Mobile phase B of concentration expressed in percentage by volume, 60~61min, concentration expressed in percentage by volume 80%-3% Mobile phase B, 61~ 70min, 3% Mobile phase B of concentration expressed in percentage by volume.
7. the method for building up of Taohong Siwu Tang preparation finger according to claim 1, it is characterised in that: step (1) Described in the preparation method of Taohong Siwu Tang granule be: take 9 parts of radix rehmanniae recen, 3 parts of Rhizoma Chuanxiong, 12 parts of Radix Angelicae Sinensis, 3.78 parts of peach kernel, 4.5 parts of Radix Paeoniae Alba and 3 parts of safflower, the above Six-element, add water to cook it is secondary, 1 hour every time, for the first time plus whole 12 times of weight of medicine materical crude slice Water, for the second time plus the water of whole 10 times of weight of medicine materical crude slice, decocting liquid filtration, filtrate merge, and filtrate decompression is concentrated into thick paste, and thick paste depressurizes Dry to solid, auxiliary material is added in crushing, is pelletized, whole grain is to get Taohong Siwu Tang granule.
8. a kind of Taohong Siwu Tang preparation finger described in claim 1, it is characterised in that: finger-print includes 28 total There is peak, each shared peak relative retention time is respectively as follows: with referring to peak relative retention time ratio
No. 1 peak relative retention time RRT is 0.16;No. 2 peak relative retention time RRT are 0.22;The relative retention time at No. 3 peaks RRT is 0.24;No. 4 peak relative retention time RRT are 0.27;No. 5 peak relative retention time RRT are 0.33;No. 6 peaks are opposite to be retained Time RRT is 0.36;No. 7 peak relative retention time RRT are 0.38;No. 8 peak relative retention time RRT are 0.48;No. 9 peaks are opposite Retention time RRT is 0.54;No. 10 peak relative retention time RRT are 0.57;No. 11 peak relative retention time RRT are 0.58;12 Number peak relative retention time RRT is 0.65;No. 13 peak relative retention time RRT are 0.66;No. 14 peak relative retention time RRT are 0.72;No. 15 peak relative retention time RRT are 0.76;No. 16 peak relative retention time RRT are 0.79;When No. 17 peaks retain relatively Between RRT be 0.81;No. 18 peak relative retention time RRT are 0.83;No. 19 peak relative retention time RRT are 0.88;No. 20 peak phases It is 1.00 to retention time RRT;No. 21 peak relative retention time RRT are 1.16;No. 22 peak relative retention time RRT are 1.19; No. 23 peak relative retention time RRT are 1.23;No. 24 peak relative retention time RRT are 1.26;No. 25 peak relative retention time RRT It is 1.36;No. 26 peak relative retention time RRT are 1.43;No. 27 peak relative retention time RRT are 1.49;No. 28 peaks are opposite to be retained Time RRT is 1.53;Wherein: No. 20 peaks S are referring to peak.
9. Taohong Siwu Tang preparation finger according to claim 8, it is characterised in that: No. 6 peaks are not in shared peak Gallate-based, No. 10 peaks are tryptophan, and No. 14 peaks are amarogentin, and No. 15 peaks are chlorogenic acid, and No. 19 peaks are Sydroxy carthamin A, No. 20 peaks are Paeoniflorin, and No. 21 peaks are ferulic acid, and No. 24 peaks are acteoside, and No. 28 peaks are Ligustilide.
CN201910931400.7A 2019-09-29 2019-09-29 The method for building up and its finger-print of Taohong Siwu Tang preparation finger Withdrawn CN110487941A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910931400.7A CN110487941A (en) 2019-09-29 2019-09-29 The method for building up and its finger-print of Taohong Siwu Tang preparation finger

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910931400.7A CN110487941A (en) 2019-09-29 2019-09-29 The method for building up and its finger-print of Taohong Siwu Tang preparation finger

Publications (1)

Publication Number Publication Date
CN110487941A true CN110487941A (en) 2019-11-22

Family

ID=68544643

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910931400.7A Withdrawn CN110487941A (en) 2019-09-29 2019-09-29 The method for building up and its finger-print of Taohong Siwu Tang preparation finger

Country Status (1)

Country Link
CN (1) CN110487941A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114636779A (en) * 2022-03-29 2022-06-17 陕西科技大学 Method for constructing sanhua decoction reference sample freeze-dried powder fingerprint spectrum and fingerprint spectrum thereof
CN114924021A (en) * 2022-03-21 2022-08-19 海南康茂信医药科技有限公司 Detection method of peach-red Siwu decoction formula
CN114636779B (en) * 2022-03-29 2024-05-24 陕西盘龙药业集团股份有限公司 Construction method of three-conversion soup reference sample freeze-dried powder fingerprint and fingerprint thereof

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114924021A (en) * 2022-03-21 2022-08-19 海南康茂信医药科技有限公司 Detection method of peach-red Siwu decoction formula
CN114924021B (en) * 2022-03-21 2023-12-08 海南康茂信医药科技有限公司 Detection method of Taohong Siwu decoction prescription
CN114636779A (en) * 2022-03-29 2022-06-17 陕西科技大学 Method for constructing sanhua decoction reference sample freeze-dried powder fingerprint spectrum and fingerprint spectrum thereof
CN114636779B (en) * 2022-03-29 2024-05-24 陕西盘龙药业集团股份有限公司 Construction method of three-conversion soup reference sample freeze-dried powder fingerprint and fingerprint thereof

Similar Documents

Publication Publication Date Title
CN106018576B (en) A kind of method for building up of Zaizao Pill UPLC finger-prints
CN106501434A (en) A kind of HPLC finger print measuring methods of Double Harmonizing Decoction standard soup
CN106483213B (en) The method for building up and finger-print of Taohe Chengqi decoction composition finger-print
CN109001346A (en) The method for building up and its finger-print of wuwei xiaodu drink preparation finger
CN106370749A (en) Quality detection method of ginseng basis-consolidating oral solution
CN111175428B (en) Method for detecting fingerprint of kidney-tonifying pregnancy-assisting granules
CN105181848A (en) UPLC fingerprint spectrum detection method of xuefu zhuyu decoction and capsules
CN106404942B (en) A kind of construction method and its standard finger-print of kidney-healing particle finger-print
CN114609291B (en) Fingerprint detection method for traditional Chinese medicine compound consistent decoction
CN114609269B (en) Detection method of Qingjin Yiqi composition and fingerprint construction method thereof
CN106706786A (en) Method for determining content of six ginsenoside ingredients of folium ginseng
CN109254096A (en) The method of quality control of jichuan decoction preparation
CN105486762B (en) A kind of high-efficiency liquid-phase fingerprint detection method of female clever ball
CN108459128A (en) A kind of method of quality control of danggui sini decoction composition
CN110487941A (en) The method for building up and its finger-print of Taohong Siwu Tang preparation finger
CN114689780A (en) Multi-component quality detection method for Baoyin decoction extract
CN111879884A (en) Quality control method of Chinese medicinal preparation
CN106526000B (en) The method for building up and finger-print of Shengma Gegen Tang composition finger-print
CN113820422B (en) Fingerprint detection method for total glucosides of white paeony
CN109239250A (en) The measuring method and its standard finger-print of sharp brain lamination finger-print
CN111562324B (en) Method for detecting contents of multiple index components of breast-eliminating and stasis-removing capsule
CN108226325A (en) Roripa montana gives birth to the method for building up of arteries and veins oral liquid composition finger-print
CN107064402B (en) A kind of nourishing qi and blood, tonifying kidney and strengthening yang pharmaceutical preparation detection method
CN109781884A (en) A kind of method for building up and its finger-print of QIANLIEXIN JIAONANG finger-print
CN109507310A (en) Support the fingerprint map construction method and detection method of the beautiful prescription of essence kind

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication

Application publication date: 20191122

WW01 Invention patent application withdrawn after publication